David Deon

David Deon has extensive experience in the pharmaceutical industry, with a focus on commercial operations and analytics. David currently holds the position of VP, Commercial Operations and Analytics at Syndax Pharmaceuticals since October 2019. Prior to that, they worked as the Head of Commercial Analytics at Loxo Oncology, Inc. from April 2018 to September 2019.

David also spent a significant portion of their career at Pfizer, where they held various roles. From January 2014 to April 2018, they served as the Director of Planning & Innovation (Commercial Excellence) for Pfizer Oncology, where they led strategic planning, launch planning, and developed HCP launch targeting for several products. David was also involved in cross-functional collaboration and financial modeling.

Before that, David held the position of Director of Strategy, Analytics & Insights Group for Pfizer Oncology from October 2011 to December 2013. In this role, they led strategic planning for the RCC portfolio and developed financial models for payer negotiations.

David's earlier experience includes working as a Senior Manager of Oncology Market Analytics at Pfizer from January 2010 to October 2011. In this role, they conducted market analytics, supported business development assessments, and developed forecasts for various products.

Prior to their tenure at Pfizer, David worked at Forest Laboratories (now Allergan) as a Manager of Market Research from February 2005 to December 2009. Here, they provided market research inputs for commercial assessments and led market research for pre-launch products.

David began their career at Datamonitor as a Senior Managing Analyst in the Healthcare Strategy Group from July 2001 to February 2005. In this role, they directed the digital component of the group's service offering and was responsible for consulting and syndicated projects.

Overall, David Deon has a strong background in commercial operations, analytics, strategic planning, and market research within the pharmaceutical industry.

David Deon completed their MBA in Finance and Marketing at NYU Stern School of Business from 2004 to 2007. Prior to that, they obtained a BS in Biological Sciences from Cornell University, where they studied from 1994 to 1998. Their secondary education was completed at Stuyvesant High School from 1990 to 1994, although no specific degree or field of study was provided for that period.